In Canada, the patent for some semaglutide drugs has expired, paving the way for the country to become the first to offer ...

Insuring early-stage R&D companies means navigating a web of unknowns. That’s not new - but the speed and scale of growth in ...

The pill was approved by the U.S. Food and Drug Administration last month, a boon to Novo Nordisk as it looks to regain ...

Every year, extreme weather events wreak havoc across Canada, disrupting the lives of tens of thousands. Financial losses ...

The death of 44-year-old Indian-origin engineer Prashant Sreekumar in an Edmonton hospital has sharpened focus on deep ...

WASHINGTON — Federal health officials are unilaterally reducing the number of recommended pediatric immunizations in response ...

The death of Prashant Sreekumar, 44, a father of three in Canada last week, is shedding light on the poor state of its ...

Entente Education Canada launches new name, new leadership and bold new direction The transition brings together several ...

Ozempic and Wegovy – two brand-name semaglutide drugs prescribed for diabetes and weight loss – will lose market exclusivity ...

In early 2026, the Intact Centre will publish a report documenting spikes in mental health related claims — including ...

The MarketWatch News Department was not involved in the creation of this content. Toronto, Dec. 16, 2025 (GLOBE NEWSWIRE) -- As RTOERO prepares to enter the new year with a new name--Entente Education ...

Top claims reasons cited were heart-related conditions, cancer and cataract. At the same time, infectious and seasonal ...